Arginine methylation as a potential therapeutic target in high-risk neuroblastoma
Arginine methylation as a potential therapeutic target in high-risk neuroblastoma
University of Rochester, Rochester, NY
Clinical Trial Decision Aid (DECIDES) for Adolescents and Young Adults with Cancer and their Caregivers
Clinical Trial Decision Aid (DECIDES) for Adolescents and Young Adults with Cancer and their Caregivers
Children’s Hospital of Philadelphia, Philadelphia, PA
Activation of NF-kB in Neuroblastoma Myeloid Cells
Activation of NF-kB in Neuroblastoma Myeloid Cells
Johns Hopkins University School of Medicine, Baltimore, MD
Molecular Mechanism of CAR Activation in Targeting B Cell Leukemia
Molecular Mechanism of CAR Activation in Targeting B Cell Leukemia
Yale University, New Haven, CT
Disrupting Neuroblastoma Tumor-Initiating Cells
Disrupting Neuroblastoma Tumor-Initiating Cells
University of Rochester, Rochester, NY
Preclinical Development of Novel Immunotherapies for Pediatric Acute Myeloid Leukemia (AML)
Preclinical Development of Novel Immunotherapies for Pediatric Acute Myeloid Leukemia (AML)
Children’s Hospital of Philadelphia, Philadelphia, PA
Tumorigenesis of a Pediatric Liver Cancer
Tumorigenesis of a Pediatric Liver Cancer
The Rockefeller University, New York, NY
Defining Actionable Apoptotic Dependencies in Pediatric CNS Tumors
Defining Actionable Apoptotic Dependencies in Pediatric CNS Tumors
John B. Little Center for Radiation Sciences, Harvard Chan School, Boston, MA
Epigenetic Therapy in AML
Epigenetic Therapy in AML
Nemours/A.I. DuPont Hospital, Wilmington, DE
Phase II Ewing’s Sarcoma Clinical Trial
Phase II Ewing’s Sarcoma Clinical Trial
Nemours/A.I. DuPont Hospital, Wilmington, DE
Zebrafish Models of Human AML
Zebrafish Models of Human AML
Dana-Farber/Harvard Medical Center, Boston, MA